bladder cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Suitable for bladder tumor patients undergoing transurethral bladder tumor resection; Patients without upper urinary tract malformations; Patients who have undergone imaging examinations (including ultrasound, CT, MRI, or PET-CT) and have not found any extravesical invasion, lymph node metastasis, or other organ metastasis. Patients who did not experience muscle layer infiltration (i.e. those with a VI-RADS score of 1-3) as assessed by preoperative magnetic resonance imaging. Participants voluntarily participate in this trial and have signed an informed consent form; Age range from 18 to 75 years old, regardless of gender. Individuals with full capacity for civil conduct;
Exclusion criteria
Exclusion criteria: Patients with severe underlying diseases such as heart, lung, liver, kidney, and blood that cannot tolerate general anesthesia or surgery; Patients who are unable to cooperate with standardized treatment or follow-up; Patients with too many tumors or a single tumor with a diameter that is too large for researchers to determine that surgery cannot be completed through intracavitary surgery, or patients with extremely high risk stratification; Patients with a high likelihood of low-risk NMIBC are determined based on preoperative imaging and cystoscopy, which simultaneously meet the criteria of primary, single, diameter less than 3cm, and preoperative cystoscopy (if any) shows papillary structure, slender pedicle, no necrosis or ulcer on the surface. Patients who participate in other clinical trials within one month of the perioperative period; The researchers believe that it is not appropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Perioperative complications; | — |
Countries
China
Contacts
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology